Zimmer Biomet Holdings Inc [ZBH] stock prices are up 0.60% to $90.57 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ZBH shares have gain 2.33% over the last week, with a monthly amount drifted -8.86%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on November 06, 2025, when JP Morgan downgraded its rating to a Neutral but kept the price target unchanged to $100 for it. Previously, Rothschild & Co Redburn started tracking the stock with Buy rating on September 18, 2025, and set its price target to $130. On July 15, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $135 on the stock. JP Morgan upgraded its rating to a Overweight and increased its price target to $128 on December 17, 2024. Wolfe Research initiated its recommendation with a Peer Perform. Piper Sandler downgraded its rating to Neutral for this stock on July 01, 2024, and downed its price target to $115. In a note dated May 30, 2024, Goldman initiated an Neutral rating and provided a target price of $129 on this stock.
The stock price of Zimmer Biomet Holdings Inc [ZBH] has been fluctuating between $85.33 and $114.72 over the past year. Currently, Wall Street analysts expect the stock to reach $112.29 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $90.57 at the most recent close of the market. An investor can expect a potential return of 23.98% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
The Zimmer Biomet Holdings Inc [NYSE:ZBH] reported sales of 8.01B for trailing twelve months, representing a surge of 9.71%. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.06 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 89.68 points at the first support level, and at 88.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 91.27, and for the 2nd resistance point, it is at 91.97.
Ratios To Look Out For
It’s worth pointing out that Zimmer Biomet Holdings Inc [NYSE:ZBH]’s Current Ratio is 2.43. In addition, the Quick Ratio stands at 1.39 and the Cash Ratio stands at 0.72. Considering the valuation of this stock, the price to sales ratio is 2.24, the price to book ratio is 1.41 and price to earnings (TTM) ratio is 22.41.
Transactions by insiders
Recent insider trading involved Yi Sang, Group President, Asia Pacific, that happened on Sep 11 ’25 when 1200.0 shares were sold. Officer, Yi Sang completed a deal on Sep 11 ’25 to buy 1200.0 shares. Meanwhile, SVP and CHRO Winkler Lori sold 1500.0 shares on Sep 08 ’25.
